The Bladder Cancer Advocacy Network (BCAN) is pleased to announce that the Bladder Cancer Research Innovation Award is now open for Letter of Intent submissions until Wednesday, January 12, 2022.

The BCAN Bladder Cancer Research Innovation Awards support novel, high risk, high reward projects with great potential to produce breakthroughs in our understanding of bladder cancer. The proposed research may be basic, translational, clinical or epidemiological and must have direct applicability and relevance to bladder cancer. Applications must include innovative approaches and new ideas to be eligible for funding.

These awards are available to full time, experienced, independent investigators affiliated with non-profit academic, medical or research institutions within the United States or Canada. Eligible applicants include investigators who have experience in other areas of cancer or biomedical and health science research with promising approaches that can be applied to bladder cancer research.

BCAN will offer two Bladder Cancer Research Innovation Awards in 2022. Both awarded proposals will be funded for $300,000 for two years ($150,000 per year).

Interested applicants must submit a Letter of Intent by Wednesday, January 12, 2022 by 5:00 PM EST and must be invited to submit a full application.

BCAN encourages you to share this announcement with appropriate listservs and colleagues within your networks and to visit BCAN’s website here for more information and detailed application instructions.

Please visit bcan.org or contact grants@bcan.org with any questions.